AmbioPharm is a global peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA. It specializes in developing highly efficient manufacturing processes for peptide-based APIs at small to large scales. The company operates two cGMP-compliant manufacturing facilities, one in South Carolina, USA, and another in Shanghai, China, where it manufactures new chemical entity (NCE) peptide APIs for clients worldwide. Both facilities have been inspected multiple times by the FDA with positive outcomes. AmbioPharm can handle all types of peptide manufacturing, from research to cGMP.
The FDA-inspected, USA-based Peptide Manufacturer with the Largest Worldwide Capacity.
Related Companies
Market Place
